BILIARY TRACT DISORDER side effect
What is BILIARY TRACT DISORDER ?Drugs associated with BILIARY TRACT DISORDER
AMBISOME ATORVASTATIN AVONEX BEVACIZUMAB BYETTA CHANTIX EFFEXOR FORTEO HARNAL HUMIRA KEFLEX LEXAPRO LIPAXAN METFORMIN NICODERM PROGRAF SORIATANE STALEVO THYMOGLOBULIN TOPAMAX ZOLOFTBILIARY TRACT DISORDER : Prograf Side Effects Report #5670353-5
Health Professional from UNITED STATES reported PROGRAF problem on Mar 03, 2008. Female patient, 60 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, . PROGRAF dosage: 5 MG. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE ACETATE, BACTRIM, ASPIRIN. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Avonex Side Effects Report #5678757-1
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, gastrointestinal motility disorder, hypertrophy, intestinal obstruction, pancreatic disorder, procedural complication, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Humira Side Effects Report #5628431-2
Physician from CANADA reported HUMIRA problem on Feb 05, 2008. Female patient, 36 years of age, was diagnosed with ankylosing spondylitis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, bleeding time prolonged, leukopenia, . HUMIRA dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Stalevo Side Effects Report #5630011-X
STALEVO problem was reported by a Pharmacist from FINLAND on Feb 08, 2008. Male patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, diarrhoea, . STALEVO dosage: unknown. During the same period patient was treated with MADOPAR CR. Patient recovered.
BILIARY TRACT DISORDER : Soriatane Side Effects Report #5583876-4
Physician from UNITED STATES reported SORIATANE problem on Dec 26, 2007. Male patient was diagnosed with transient acantholytic dermatosis and was treated with SORIATANE. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatic steatosis, pancreatitis chronic, . SORIATANE dosage: 25 MG;QD;PO. During the same period patient was treated with DIOVAN, FLURAZEPAM, NEXIUM, ZANTAC, FLOMAX, ANDROGEL, LAMISIL. Patient recovered.
BILIARY TRACT DISORDER : Chantix Side Effects Report #5596860-1
CHANTIX problem was reported by a Physician from UNITED STATES on Jan 09, 2008. Female patient was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, liver function test abnormal, . CHANTIX dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Stalevo Side Effects Report #5597251-X
Pharmacist from FINLAND reported STALEVO problem on Jan 14, 2008. Male patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, diarrhoea, . STALEVO dosage: unknown. During the same period patient was treated with MADOPAR CR. Patient recovered.
BILIARY TRACT DISORDER : Ambisome Side Effects Report #5605741-6
AMBISOME problem was reported by a Health Professional from AUSTRALIA on Jan 16, 2008. Male patient, 59 years of age, weighting 260.1 lb, was diagnosed with acute myeloid leukaemia and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatic encephalopathy, hepatitis acute, hepatorenal failure, injury, nephritis interstitial, sepsis, . AMBISOME dosage: 30 MG, UID/QD, IV DRIP. During the same period patient was treated with IDARUBICIN, ETOPOSIDE, CYTARABINE, VANCOMYCIN HYDROCHLORIDE, MEROPENEM, AZITHROMYCIN. Patient was hospitalized and became disabled. Patient recovered.
BILIARY TRACT DISORDER : Harnal Side Effects Report #5575392-0
Physician from JAPAN reported HARNAL problem on Dec 20, 2007. Male patient, weighting 145.5 lb, was diagnosed with benign prostatic hyperplasia, cerebral infarction, hypertension, constipation, diabetes mellitus and was treated with HARNAL. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, liver disorder, . HARNAL dosage: unknown. During the same period patient was treated with BUFFERIN, RENIVEZE, OZAGREL, SENNOSIDE, CETILO, INSULINECTION. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Prograf Side Effects Report #5509483-7
PROGRAF problem was reported by a Health Professional from UNITED STATES on Oct 26, 2007. Female patient, 60 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, . PROGRAF dosage: 5 MG, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, BACTRIM, ASPIRIN. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Forteo Side Effects Report #5517529-5
Consumer or non-health professional from SPAIN reported FORTEO problem on Oct 31, 2007. Female patient, 71 years of age, was diagnosed with osteoporosis, pain and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, . FORTEO dosage: unknown. During the same period patient was treated with PARACETAMOL, NOLOTIL. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Thymoglobulin Side Effects Report #5484982-5
THYMOGLOBULIN problem was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, 59 years of age, weighting 170.2 lb, was diagnosed with liver transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatitis, hepatitis c virus, oedema, . THYMOGLOBULIN dosage: 110 MG DAILY IV. During the same period patient was treated with CALCIUM SUPPLEMENT, CELLCEPT, NEURONTIN, BACTRIM DS, FLORNINEF, VORICONAZOLE. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Atorvastatin Side Effects Report #5487435-3
Consumer or non-health professional from UNITED STATES reported ATORVASTATIN CALCIUM problem on Oct 05, 2007. Male patient, weighting 216.5 lb, was diagnosed with coronary artery disease and was treated with ATORVASTATIN CALCIUM. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, cholecystitis, hypoxia, . ATORVASTATIN CALCIUM dosage: DAILY DOSE:20MG. During the same period patient was treated with ATORVASTATIN CALCIUM, AMLODIPINE, SILDENAFIL, VITAMIN CAP, ASPIRIN, IBUPROFEN, PIMECROLIMUS, TRAZODONE. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Zoloft Side Effects Report #5498035-3
ZOLOFT problem was reported by a Consumer or non-health professional from SWEDEN on Oct 15, 2007. Male patient, 65 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, memory impairment, pancreatic neoplasm, . ZOLOFT dosage: unknown. During the same period patient was treated with ZOPICLONE, PROPAVAN. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Byetta Side Effects Report #5499570-4
Physician from UNITED STATES reported BYETTA problem on Oct 18, 2007. Male patient, weighting 210.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, blood glucose decreased, blood glucose increased, malaise, post procedural bile leak, vomiting, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Ambisome Side Effects Report #5449654-1
AMBISOME problem was reported by a Health Professional from AUSTRALIA on Aug 27, 2007. Male patient, 59 years of age, weighting 260.1 lb, was diagnosed with acute myeloid leukaemia and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, blood creatinine increased, hepatic encephalopathy, hepatic function abnormal, hepatitis acute, nephritis interstitial, pyrexia, renal impairment, . AMBISOME dosage: 30 MG, UID/QD, IV DRIP. During the same period patient was treated with IDARUBICIN, ETOPOSIDE, CYTARABINE, VANCOMYCIN HYDROCHLORIDE, MEROPENEM, AZITHROMYCIN. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Atorvastatin Side Effects Report #5467309-4
Consumer or non-health professional from UNITED STATES reported ATORVASTATIN CALCIUM problem on Sept 17, 2007. Male patient, weighting 216.5 lb, was diagnosed with coronary artery disease and was treated with ATORVASTATIN CALCIUM. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, cholecystitis, hypoxia, . ATORVASTATIN CALCIUM dosage: DAILY DOSE:20MG. During the same period patient was treated with ATORVASTATIN CALCIUM, AMLODIPINE, SILDENAFIL, VITAMIN CAP, ASPIRIN, IBUPROFEN, PIMECROLIMUS, TRAZODONE. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Keflex Side Effects Report #5469188-8
KEFLEX problem was reported by a Physician from UNITED STATES on Sept 26, 2007. Female patient, 41 years of age, was treated with KEFLEX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatic fibrosis, hepatic steatosis, hepatitis, liver disorder, lymphocytic infiltration, myopathy, peripheral ischaemia, . KEFLEX dosage: unknown. During the same period patient was treated with OMNICEF. Patient recovered.
BILIARY TRACT DISORDER : Ambisome Side Effects Report #5421591-8
Health Professional from AUSTRALIA reported AMBISOME problem on July 30, 2007. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, blood creatinine increased, hepatic encephalopathy, hepatic function abnormal, hepatitis, hepatitis acute, nephritis interstitial, pyrexia, . AMBISOME dosage: 30 MG, UID/QD, IV DRIP. During the same period patient was treated with IDARUBICIN, ETOPOSIDE, CYTARABINE, VANCOMYCIN HYDROCHLORIDE, MEROPENEM, AZITHROMYCIN. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Topamax Side Effects Report #5385294-0
TOPAMAX problem was reported by a Health Professional from PORTUGAL on July 02, 2007. Female patient, 50 years of age, was diagnosed with weight loss diet, migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, gamma-glutamyltransferase increased, . TOPAMAX dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Lexapro Side Effects Report #5391831-2
Health Professional from UNITED STATES reported LEXAPRO problem on July 06, 2007. Female patient was treated with LEXAPRO. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, congenital anomaly, cyst, foetal disorder, . LEXAPRO dosage: 20 MG QD TRANSPLACENTAL. During the same period patient was treated with PRENATAL VITAMINS. Patient recovered.
BILIARY TRACT DISORDER : Topamax Side Effects Report #5395268-1
TOPAMAX problem was reported by a Health Professional from PORTUGAL on July 17, 2007. Female patient, 50 years of age, was diagnosed with weight loss diet, migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, gamma-glutamyltransferase increased, . TOPAMAX dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Topamax Side Effects Report #5385294-0
Health Professional from PORTUGAL reported TOPAMAX problem on July 02, 2007. Female patient, 50 years of age, was diagnosed with weight loss diet, migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, gamma-glutamyltransferase increased, . TOPAMAX dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Lexapro Side Effects Report #5391831-2
LEXAPRO problem was reported by a Health Professional from UNITED STATES on July 06, 2007. Female patient was treated with LEXAPRO. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, congenital anomaly, cyst, foetal disorder, . LEXAPRO dosage: 20 MG QD TRANSPLACENTAL. During the same period patient was treated with PRENATAL VITAMINS. Patient recovered.
BILIARY TRACT DISORDER : Topamax Side Effects Report #5395268-1
Health Professional from PORTUGAL reported TOPAMAX problem on July 17, 2007. Female patient, 50 years of age, was diagnosed with weight loss diet, migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, gamma-glutamyltransferase increased, . TOPAMAX dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Avonex Side Effects Report #5619223-9
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2008. Female patient was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: asthenia, biliary tract disorder, crying, emotional disorder, haemorrhage, hypoacusis, influenza, liver disorder, mass, . AVONEX dosage: unknown. Patient recovered.
BILIARY TRACT DISORDER : Prograf Side Effects Report #5535082-7
Physician from JAPAN reported PROGRAF problem on Nov 15, 2007. Male patient, 67 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: back pain, biliary tract disorder, continuous haemodiafiltration, hepatic fibrosis, hepatitis b, hepatitis cholestatic, hyperplasia, pancreatitis acute, . PROGRAF dosage: unknown. During the same period patient was treated with STEROIDMULATION. Patient died.
BILIARY TRACT DISORDER : Lipaxan Side Effects Report #5474049-4
LIPAXAN problem was reported by a Consumer or non-health professional from ITALY on Sept 26, 2007. Female patient, 68 years of age, was diagnosed with dyslipidaemia and was treated with LIPAXAN. After drug was administered, patient experienced the following problems/side effects: aphonia, biliary tract disorder, blood creatine phosphokinase increased, chromaturia, dyspnoea, liver disorder, myalgia, myoglobin blood increased, rhabdomyolysis, . LIPAXAN dosage: 80 MG/D. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.
BILIARY TRACT DISORDER : Humira Side Effects Report #5491153-5
Consumer or non-health professional from BRAZIL reported HUMIRA problem on Oct 10, 2007. Female patient, 48 years of age, weighting 103.6 lb, was diagnosed with rheumatoid arthritis, arthralgia, anaemia, blood bilirubin decreased and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, biliary tract disorder, cholelithiasis, hepatitis, hepatomegaly, lung injury, pain in extremity, procedural complication, rheumatoid arthritis, . HUMIRA dosage: unknown. During the same period patient was treated with METAMIZOLE, PARACETAMOL, PREDNISONE, METHYLPREDNISOLONE, WHOLE BLOOD, BILIRUBIN, ALIMENTARY COMPLEMENT. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Lipaxan Side Effects Report #5463986-2
LIPAXAN problem was reported by a Consumer or non-health professional from ITALY on Sept 17, 2007. Female patient, 68 years of age, was diagnosed with dyslipidaemia and was treated with LIPAXAN. After drug was administered, patient experienced the following problems/side effects: aphonia, biliary tract disorder, blood creatine phosphokinase increased, dyspnoea, liver disorder, myalgia, myoglobin blood increased, rhabdomyolysis, . LIPAXAN dosage: 80 MG, UNK. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.
BILIARY TRACT DISORDER : Lipaxan Side Effects Report #5467254-4
Consumer or non-health professional from ITALY reported LIPAXAN problem on Sept 18, 2007. Female patient, 68 years of age, was diagnosed with dyslipidaemia and was treated with LIPAXAN. After drug was administered, patient experienced the following problems/side effects: aphonia, biliary tract disorder, blood creatine phosphokinase increased, chromaturia, dyspnoea, liver disorder, myalgia, myoglobin blood increased, rhabdomyolysis, . LIPAXAN dosage: 80 MG, UNK. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.
BILIARY TRACT DISORDER : Effexor Side Effects Report #5409852-X
EFFEXOR problem was reported by a Physician from FRANCE on Aug 02, 2007. Male patient was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, biliary tract disorder, cholangitis sclerosing, disturbance in attention, dysaesthesia, gamma-glutamyltransferase increased, hepatic infiltration eosinophilic, vision blurred, . EFFEXOR dosage: 250 MG TOTAL DAILY. Patient recovered.
BILIARY TRACT DISORDER : Metformin Side Effects Report #5428577-8
Physician from UNITED STATES reported METFORMIN problem on Aug 13, 2007. Male patient, 54 years of age, was diagnosed with type 2 diabetes mellitus and was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, biliary tract disorder, coronary artery occlusion, diabetes mellitus inadequate control, electrocardiogram abnormal, lymphoma, portal vein occlusion, sarcoidosis, . METFORMIN dosage: 2000 MG (1000 MG, 2 IN 1D). During the same period patient was treated with ASPIRIN, ACCUPRIL, LESCOL, ACETAMINOPHEN, CIALIS. Patient was hospitalized. Patient recovered.
BILIARY TRACT DISORDER : Nicoderm Side Effects Report #5670704-1
NICODERM CQ problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Female patient, 42 years of age, weighting 127.2 lb, was treated with NICODERM CQ. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, adnexa uteri pain, biliary tract disorder, gastrointestinal pain, hepatic enzyme increased, ovarian cyst, . NICODERM CQ dosage: 7MG PER DAY. During the same period patient was treated with ESTROGEN. Patient recovered.
BILIARY TRACT DISORDER : Lipaxan Side Effects Report #5491471-0
Consumer or non-health professional from ITALY reported LIPAXAN problem on Oct 11, 2007. Female patient, 68 years of age, was diagnosed with hypercholesterolaemia and was treated with LIPAXAN. After drug was administered, patient experienced the following problems/side effects: albuminuria, aphonia, biliary tract disorder, blood albumin increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, . LIPAXAN dosage: 80 MG/D. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.
BILIARY TRACT DISORDER : Bevacizumab Side Effects Report #5463044-7
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Sept 18, 2007. Female patient, weighting 158.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary tract disorder, blood bilirubin increased, obstruction, . BEVACIZUMAB dosage: 720MG Q2WKS INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
BILIARY TRACT DISORDER : Bevacizumab Side Effects Report #5463053-8
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Sept 18, 2007. Female patient, weighting 158.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary tract disorder, blood bilirubin increased, obstruction, . BEVACIZUMAB dosage: 720MG Q2WKS IV. Patient recovered.
BILIARY TRACT DISORDER : Prograf Side Effects Report #5472217-9
PROGRAF problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Male patient, 24 years of age, was diagnosed with heart transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, ascites, biliary tract disorder, bronchial neoplasm, bronchopneumonia, bronchoscopy abnormal, cardiac cirrhosis, cardiac valve vegetation, clostridium difficile colitis, . PROGRAF dosage: 0.5 MG, UID/QD; 2 MG, BID; 1 MG, BID; 2 MG, BID; 5 MG, QID,. During the same period patient was treated with SIROLIMUS, DACLIZUMAB, CELLCEPT, PREDNISONE. Patient was hospitalized. Patient died on 02/01/2004.